Semenogelin II (SEMG2) (N-Term) Peptid
Kurzübersicht für Semenogelin II (SEMG2) (N-Term) Peptid (ABIN8111314)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- SEMG2 Peptide - N-terminal region
-
Sequenz
- GQKGQHYFGQ KDQQHTKSKG SFSIQHTYHV DINDHDWTRK SQQYDLNALH
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-SEMG2 Antibody(ARP42092_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SEMG2 (Semenogelin II (SEMG2))
-
Hintergrund
-
Background Information: The secreted protein encoded by this gene is involved in the formation of a gel matrix that encases ejaculated spermatozoa. Proteolysis by the prostate-specific antigen (PSA) breaks down the gel matrix and allows the spermatozoa to move more freely. The encoded protein is found in lesser abundance than a similar semenogelin protein. The genes encoding these two semenogelin proteins are found in a cluster on chromosome 20.
Alternative Symbols: SGII
-
Molekulargewicht
- 63kDa
-
Gen-ID
- 6407
-
NCBI Accession
- NP_002999
-
UniProt
- Q02383
Target
-